ReP USP - Resultado da busca

Artigo de periodico
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study (2022)
Tromp, Tycho R.; Hartgers, Merel L. ; Hovingh, G. Kees; Vallejo-vaz, Antonio J. ; Ray, Kausik K.; Soran, Handrean; Freiberger, Tomas; Bertolini, Stefano; Harada-shiba, Mariko; Blom, Dirk J.
Source: Lancet. Unidade: FM
Subjects: ESTUDOS DE COORTES, HIPERCOLESTEROLEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROMP, Tycho R. et al. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, v. 399, n. 10326, p. 719-728, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50469. Acesso em: 05 nov. 2024.
APA
Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-vaz, A. J., Ray, K. K., Soran, H., et al. (2022). Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, 399( 10326), 719-728. doi:10.1016/S0140-6736(21)02001-8
NLM
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
Vancouver
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
Artigo de periodico
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (2022)
Pradhan, Aruna Das; Glynn, Robert J.; Fruchart, Jean-Charles; Macfadyen, Jean G.; Zaharris, Elaine S.; Everett, Brendan M.; Campbell, Stuart E.; Oshima, Ryu; Amarenco, Pierre; Blom, Dirk J.
Source: New england journal of medicine. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADHAN, Aruna Das et al. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, v. 387, n. 21, p. 1923-1934, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50462. Acesso em: 05 nov. 2024.
APA
Pradhan, A. D., Glynn, R. J., Fruchart, J. -C., Macfadyen, J. G., Zaharris, E. S., Everett, B. M., et al. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, 387( 21), 1923-1934. doi:10.1056/NEJMoa2210645
NLM
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462
Vancouver
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462
Artigo de periodico
Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study (2018)
Blom, Dirk J.; O'dea, Louis; Digenio, Andres; Alexander, Veronica J.; Karwatowska-Prokopczuk, Ewa; Williams, Karren R.; Hemphill, Linda; Muniz-Grijalvo, Ovidio; Santos Filho, Raul Dias dos; Baum, Seth; Witztum, Joseph L.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: HIPERLIPIDEMIA, DOENÇAS GENÉTICAS, HIPERTRIGLICERIDEMIA, PANCREATITE, DIETA COM RESTRIÇÃO DE GORDURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLOM, Dirk J. et al. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study. Journal of clinical lipidology, v. 12, n. 5, p. 1234-1243, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2018.05.013. Acesso em: 05 nov. 2024.
APA
Blom, D. J., O'dea, L., Digenio, A., Alexander, V. J., Karwatowska-Prokopczuk, E., Williams, K. R., et al. (2018). Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study. Journal of clinical lipidology, 12( 5), 1234-1243. doi:10.1016/j.jacl.2018.05.013
NLM
Blom DJ, O'dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muniz-Grijalvo O, Santos Filho RD dos, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study [Internet]. Journal of clinical lipidology. 2018 ; 12( 5): 1234-1243.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jacl.2018.05.013
Vancouver
Blom DJ, O'dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muniz-Grijalvo O, Santos Filho RD dos, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study [Internet]. Journal of clinical lipidology. 2018 ; 12( 5): 1234-1243.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jacl.2018.05.013

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration